Researchers found that aspirin decreases thromboxane A2 (TXA2) production, thus preventing T cell suppression and reducing the frequency of metastases in mice models. This discovery suggests a ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

The research team discovered that platelets release a substance called thromboxane A2 (TXA2), which attaches to receptors on T cells and activates a protein called ARHGEF1. This interaction suppresses ...

The new research suggests a path for aspirin to become a cancer treatment - but people are being warned not to start taking ...

Essentially, aspirin can boost the immune system’s ability to fight cancer metastasis by stopping platelets — tiny blood ...

A team of researchers from the University of Cambridge believe they have uncovered the mechanism behind how aspirin, a common ...

"New study shows aspirin may prevent cancer spread by enhancing immune system's ability to attack metastatic cells. Findings ...

Scientists found that aspirin blocks TXA2, freeing T cells to fight cancer. This discovery could help prevent metastasis, but ...

Scientists share how they discovered that aspirin could potentially help to prevent cancer spread in the body.

The anti-clotting effect of aspirin may trigger a biological chain of events that stops cancer cells from metastasizing, ...

This breakthrough paves the way for more accessible and targeted treatments. Aspirin works by inhibiting the production of thromboxane A2 (TXA2), a molecule produced by blood platelets. TXA2, known ...